Today's Research: Elan Corp. PLC, Amarin Corp. PLC, Seattle Genetics Inc., and Cubist Pharmaceuticals Inc.

LONDON, August 8, 2013 /PRNewswire/ --

On Wednesday, August 7, 2013, all three benchmark indexes closed lower, with the Dow Jones Industrial Average falling 0.31%, the S&P 500 falling 0.38%, and the NASDAQ declining 0.32%. Shares in healthcare companies also ended mostly lower. The major movers included Elan Corp. PLC (NYSE: ELN), Amarin Corp. PLC (NASDAQ: AMRN), Seattle Genetics Inc. (NASDAQ: SGEN), and Cubist Pharmaceuticals Inc. (NASDAQ: CBST). AAAResearchReports.com has completed its technical analysis on ELN, AMRN, SGEN, and CBST and these free reports are accessible by registering at:

http://www.aaaresearchreports.com/register/  

Shares in Elan Corp. PLC ended slightly higher on Wednesday, extending their gains from the last trading session. The company's shares ended the day 0.13% higher at $15.74 after oscillating between $15.68 and $15.79. A total of 7.83 million shares were traded, which is below the daily average volume of 13.73 million. The stock has gained 11.55% in the last one month and 36.87% in the last three months. Moreover, the stock is currently trading near its 52-week high of $15.92. Sign up for free technical research on ELN at:

http://www.AAAResearchReports.com/ELN080813.pdf

Shares in Amarin Corp. PLC fell sharply on Wednesday, ending the day at $5.27, down 2.77% from the previous closing price. The company's shares fluctuated between $5.13 and $5.46. A total of 6.65 million shares were traded, which is above the daily average volume of 3.68 million. The stock has lost 11.58% in the past one month and 24.82% in the last three months. Further, Amarin Corp.'s shares are currently trading below their 50-day and 200-day moving averages. Be sure to read our latest technical research on AMRN by registering at:

http://www.AAAResearchReports.com/AMRN080813.pdf

Shares in Seattle Genetics Inc. moved lower on Wednesday. The company's shares oscillated between $41.25 and $42.68 before ending the session 1.22% lower at $42.03. A total of 0.83 million shares were traded, which is below the daily average volume of 1.03 million. Despite Wednesday's sharp decline, Seattle Genetics' shares have gained 20.40% in the last one month, outperforming the S&P 500 which has gained 3.62% during the same period. Sign up and read the complimentary report on SGEN at:

http://www.AAAResearchReports.com/SGEN080813.pdf

Cubist Pharmaceuticals Inc.'s stock struggled on Wednesday. The company's shares hit an intra-day low of $61.41 before finishing the day 2.30% lower at $61.54. A total of 0.76 million shares were traded, which is below the daily average volume of 1.12 million. Despite the recent pullbacks, the company's shares have gained 13.71% in the last one month and are trading above their 50-day and 200-day moving averages. The free report on CBST can be downloaded by signing up now at:

http://www.AAAResearchReports.com/CBST080813.pdf

EDITOR NOTES:

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

AAAresearchreports.com

SOURCE AAA Research Reports